Search Results - "Scheiter, Alexander"

Refine Results
  1. 1

    Identification of CD133 + intercellsomes in intercellular communication to offset intracellular signal deficit by Kaneko, Kota, Liang, Yan, Liu, Qing, Zhang, Shuo, Scheiter, Alexander, Song, Dan, Feng, Gen-Sheng

    Published in eLife (17-10-2023)
    “…CD133 (prominin 1) is widely viewed as a cancer stem cell marker in association with drug resistance and cancer recurrence. Herein, we report that with…”
    Get full text
    Journal Article
  2. 2

    Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis by Klemm, Sophie, Evert, Katja, Utpatel, Kirsten, Muggli, Alexandra, Simile, Maria M, Chen, Xin, Evert, Matthias, Calvisi, Diego F, Scheiter, Alexander

    Published in BMC cancer (09-11-2023)
    “…Upregulation of the mitogen-activated protein kinase (MAPK) cascade is common in hepatocellular carcinoma (HCC). Neuroblastoma RAS viral oncogene homolog…”
    Get full text
    Journal Article
  3. 3

    Quantification of contrast agent uptake in the hepatobiliary phase helps to differentiate hepatocellular carcinoma grade by Haimerl, Michael, Utpatel, Kirsten, Götz, Andrea, Zeman, Florian, Fellner, Claudia, Nickel, Dominik, Luerken, Lukas, Brennfleck, Frank, Stroszczynski, Christian, Scheiter, Alexander, Verloh, Niklas

    Published in Scientific reports (26-11-2021)
    “…This study aimed to assess the degree of differentiation of hepatocellular carcinoma (HCC) using Gd-EOB-DTPA-assisted magnetic resonance imaging (MRI) with T1…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Identification of CD133+ intercellsomes in intercellular communication to offset intracellular signal deficit by Kaneko, Kota, Liang, Yan, Liu, Qing, Zhang, Shuo, Scheiter, Alexander, Song, Dan, Feng, Gen-Sheng

    Published in eLife (17-10-2023)
    “…CD133 (prominin 1) is widely viewed as a cancer stem cell marker in association with drug resistance and cancer recurrence. Herein, we report that with…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Characteristics and outcome of patients with small bowel adenocarcinoma (SBA) by Teufel, Andreas, Meindl-Beinker, Nadja M., Hösel, Pauline, Gerken, Michael, Roig, Ana, Ebert, Matthias P., Herr, Wolfgang, Scheiter, Alexander, Pauer, Armin, Schlitt, Hans J., Klinkhammer-Schalke, Monika

    “…Background Small bowel adenocarcinoma (SBA) remains a rare malignancy accounting for less than 5% of all the gastrointestinal tract cancers. However, only…”
    Get full text
    Journal Article
  13. 13

    Complex Roles of PTPN11/SHP2 in Carcinogenesis and Prospect of Targeting SHP2 in Cancer Therapy by Scheiter, Alexander, Lu, Li-Chun, Gao, Lilian H, Feng, Gen-Sheng

    Published in Annual review of cancer biology (12-06-2024)
    “…The nonreceptor tyrosine phosphatase SHP2 has been at the center of cell signaling research for three decades. SHP2 is required to fully activate the…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20